细胞极性试点乳腺癌的进展和免疫抑制
Jie Huang1,2, Shufeng Luo3, Juan Shen1
1Department of Thoracic Oncology, Hangzhou Cancer Hospital, Hangzhou, Zhejiang, China.
Oncogene
|March 8, 2025
概括
破坏细胞极性 (DCP) 驱动癌症的攻击性,并损害免疫细胞的功能,创造一个免疫抑制性瘤微环境 (TME). 了解瘤免疫相互作用中的细胞极性 (CP) 是改善癌症免疫疗法的关键.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 破坏细胞极性 (DCP) 是固体癌症的一个关键特征,影响瘤进展和免疫细胞相互作用.
- 通过DCP影响瘤免疫微环境 (TME) 的精确机制仍然不完全理解.
研究的目的:
- 审查细胞极性 (CP) 蛋白在上皮平衡,癌症进展和乳腺癌中的作用.
- 评估CP在免疫细胞功能中的参与,如激活,迁移和瘤透.
- 讨论瘤和免疫细胞中的CP变化如何影响瘤免疫调节和对免疫治疗的反应.
主要方法:
- 文献综述侧重于癌症和免疫学中的细胞极性蛋白.
- 对CP在免疫细胞激活,成熟,迁移和透中的作用的当前数据的分析.
- 评估CP对抗原呈现和免疫突触形成的影响.
主要成果:
- DCP有助于瘤的攻击性,并通过损害免疫细胞功能来产生免疫抑制的TME.
- 瘤和免疫细胞上的CP状态影响抗原呈现和免疫突触形成.
- 瘤细胞和/或免疫细胞中改变的CP显著影响瘤免疫调节.
结论:
- CP介导的瘤攻击性和DCP受损的免疫细胞功能决定了免疫抑制和对免疫检查点阻塞 (ICB) 的反应.
- 对TME中CP/DCP介导的免疫调节的进一步研究对于开发有效的癌症免疫疗法至关重要.
更多相关视频
08:11Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics
Published on: March 26, 2018
7.6K
09:44Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior
Published on: June 13, 2016
8.4K
相关概念视频
Polarity of the Cytoskeleton
14.1K
The intrinsic polarity of cells can be primarily attributed to two factors- i) the asymmetric accumulation of mobile components such are regulatory molecules and subcellular components across the cell and ii) the orientation of polar cytoskeletal filaments that make up the cytoskeletal networks, specifically microfilaments, and microtubules arranged along the axis of polarity. Interactions between the cytoskeletal filaments are crucial for the establishment and maintenance of the polar nature...
14.1K
Cell Polarization by Rho Proteins
2.6K
Cell polarity is the asymmetric distribution of cellular and membrane components, making one side of the cell different from the other. This polarity is essential to many processes such as embryogenesis, axon migration, glucose transport across epithelial cells, and directional cell migration. A migrating cell responds to intracellular or extracellular signals via molecular cascades that reorganize the actin cytoskeleton to establish this polarity. In these cells, the Rho family proteins Cdc42,...
2.6K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Cancer Stem Cells and Tumor Maintenance
4.7K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.7K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
